羟氯喹与二甲双胍潜在药物相互作用信号检测
本研究基于WHO药物警戒数据库VigiBase,采用病例/非病例的不比例分析,比较羟氯喹联合二甲双胍与两药单用在致命结局报告上的差异。结果显示联合用药的ROR显著升高,提示可能存在致死风险信号,尤其涉及完成自杀。
要点
- 羟氯喹联合二甲双胍的致命结局信号强于任一单药,临床应警惕。
- 该信号主要与完成自杀相关,需关注联合用药患者的精神状态。
- 研究为药物警戒信号检测,尚不能确立因果关系。
核心结论
- 研究识别出羟氯喹联合二甲双胍较任一单药更易出现致命结局的信号,尤其表现为完成自杀。
研究设计与样本
- 比较羟氯喹或二甲双胍单药与两药联合的数据,结果以ROR及95%CI表示。
- 涉及羟氯喹的个例安全性报告共10,771份,其中52份记录为致命结局。
主要发现
- 与羟氯喹单药相比,羟氯喹联合二甲双胍的ROR为57.7(95%CI 23.9-139.3)。
- 与二甲双胍单药相比,羟氯喹联合二甲双胍的ROR为6.0(95%CI 2.6-13.8)。
- 联合用药的致命结局信号强于任一单药,尤其涉及完成自杀。
临床怎么用
- 临床对羟氯喹与二甲双胍联用患者应加强用药监护,关注自杀风险相关表现。
- 该信号需进一步研究验证,不应据此直接改变处方,但可作为药物警戒参考。
局限性
- 研究为基于自发报告数据库的信号检测,存在报告偏倚与混杂,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hydroxychloroquine was recently promoted in patients infected with COVID-19 infection. A recent experimental study has suggested an increased toxicity of hydroxychloroquine in association with metformin in mice. OBJECTIVE: The present study was undertaken to investigate the reality of this putative drug-drug interaction between hydroxychloroquine and metformin using pharmacovigilance data. METHODS: Using VigiBase®, the WHO pharmacovigilance database, we performed a disproportionality analysis (case/non-case study). Cases were reports of fatal outcomes with the drugs of interest and non-cases were all other reports for these drugs registered between 1 January 2000 and 31 December 2019. Data with hydroxychloroquine (or metformin) alone were compared with the association hydroxychloroquine + metformin. Results are reported as ROR (reporting odds ratio) with their 95% confidence interval. RESULTS: Of the 10,771 Individual Case Safety Reports (ICSR) involving hydroxychloroquine, 52 were recorded as 'fatal outcomes'. In comparison with hydroxychloroquine alone, hydroxychloroquine + metformin was associated with an ROR value of 57.7 (23.9-139.3). In comparison with metformin alone, hydroxychloroquine + metformin was associated with an ROR value of 6.0 (2.6-13.8). CONCLUSION: Our study identified a signal for the association hydroxychloroquine + metformin that appears to be more at risk of fatal outcomes (particularly by completed suicides) than one of the two drugs when given alone.
引用
- Montastruc JL, Toutain PL. A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. Drug Saf. 2020. PMID: 32495148. doi:10.1007/s40264-020-00955-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。